CADM4 and nonpapillary renal cell carcinoma: Interestingly, comprehensive data from Wang’s and our own datasets indicate that SHMT2 might enhance ccRCC tumorigenesis while impairing tumor thrombus invasion, whereas CADM4 possibly exerts opposite effects on tumorigenesis and thrombus invasion.